Sencanski, M.; Perovic, V.; Pajovic, S.B.; Adzic, M.; Paessler, S.; Glisic, S.
Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico Method. Molecules 2020, 25, 3830.
https://doi.org/10.3390/molecules25173830
AMA Style
Sencanski M, Perovic V, Pajovic SB, Adzic M, Paessler S, Glisic S.
Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico Method. Molecules. 2020; 25(17):3830.
https://doi.org/10.3390/molecules25173830
Chicago/Turabian Style
Sencanski, Milan, Vladimir Perovic, Snezana B. Pajovic, Miroslav Adzic, Slobodan Paessler, and Sanja Glisic.
2020. "Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico Method" Molecules 25, no. 17: 3830.
https://doi.org/10.3390/molecules25173830
APA Style
Sencanski, M., Perovic, V., Pajovic, S. B., Adzic, M., Paessler, S., & Glisic, S.
(2020). Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico Method. Molecules, 25(17), 3830.
https://doi.org/10.3390/molecules25173830